Warby Parker Inc.
NYSE:WRBYMedical - Instruments & Supplies
+$0.92 today
- Market cap
- $3.07B
- Beta
- 1.97
- P/E (TTM)
- 2305.1
- EPS (TTM)
- $0.01
Volume 5.90M
Average 2.81M
WRBY EBITDA Margin
EBITDA as a percentage of revenue.
Warby Parker Inc.NYSE: WRBY
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin widens to 8.2%
EBITDA Margin was 8.2% in Q2 FY2026, up 3.6 pp from a year earlier. On a trailing-twelve-month basis it was 7.0%, up 2.0 pp year over year. Over 3 fiscal years it widened by 19.2 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 10 analysts of 12.0% for the fiscal year ending Dec 2026, up from 6.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 8.2%+0.9 pp QoQ
- Last fiscal yearDec 2025
- 6.1%+2.7 pp YoY
- LTMJun 2026
- 7.0%+2.0 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.6 pp | +3.0 pp | -0.6 pp |
| 1 year | +2.7 pp | +5.9 pp | +3.2 pp |
| 3 years | +19.2 pp | +6.9 pp | -12.3 pp |
| 5 years | +9.7 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 6.1%
- Year-over-year change
- +2.7pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.1% | +2.7pp |
| FY2024 | 2024-12-31 | 3.4% | +7.0pp |
| FY2023 | 2023-12-31 | -3.6% | +9.4pp |
| FY2022 | 2022-12-31 | -13.0% | +9.5pp |
| FY2021 | 2021-12-31 | -22.6% | — |
EBITDA Margin vs competitors
How WRBY compares with its peers on the latest reported figures
- WRBY's LTM Jun 2026 EBITDA Margin of 7.0% is the 7th highest of the 10 companies compared; the peer median is 17.0%.
- Its year-over-year change of +2.0 pp is the 4th highest of 10, against a peer median of +0.5 pp.
- Over three fiscal years its change of +19.2 pp compares with a peer median of -0.2 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 37.6% | +5.3 pp | +13.5 pp | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | 20.5% | +1.3 pp | -0.2 pp |
| LTM Jun 2026 | 19.3% | -8.7 pp | -2.2 pp | |
| LTM Jun 2026 | 18.9% | -14.3 pp | -4.5 pp | |
| LTM Jul 2026 | 17.0% | +0.5 pp | -0.6 pp | |
| LTM Jun 2026 | 11.5% | -2.1 pp | +5.5 pp | |
| LTM Jun 2026 | 7.0% | +2.0 pp | +19.2 pp | |
| LTM Mar 2026 | -3.5% | +10.1 pp | +15.6 pp | |
| LTM Mar 2026 | -20.7% | -31.1 pp | -51.4 pp | |
| LTM Jun 2026 | -40.5% | +584.3 pp | +435.7 pp | |
| Peer median (excluding WRBY) | 17.0% | +0.5 pp | -0.2 pp | |
Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 540.8M | 598.11M | 669.77M | 771.32M | 871.91M |
| Cost of Revenue | 223.05M | 257.05M | 304.54M | 344.48M | 401.33M |
| Gross Profit | 317.75M | 341.06M | 365.22M | 426.83M | 470.58M |
| Gross Margin | 58.8% | 57.0% | 54.5% | 55.3% | 54.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 461.41M | 452.27M | 421.57M | 440.05M | 475.92M |
| Operating Expenses | 461.41M | 452.27M | 437.22M | 456.95M | 475.92M |
| Depreciation & Amortization | 21.87M | 31.86M | 38.55M | 45.87M | 50.28M |
| EBITDA | (122.14M) | (78.03M) | (24.21M) | 26.35M | 53.32M |
| EBITDA Margin | -22.6% | -13.0% | -3.6% | 3.4% | 6.1% |
| Operating Income | (143.66M) | (111.2M) | (72M) | (30.11M) | (5.34M) |
| Operating Margin | -26.6% | -18.6% | -10.7% | -3.9% | -0.6% |
| Interest Income | 0 | 1.31M | 9.23M | 10.6M | 8.38M |
| Interest Expense | 347K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (347K) | 1.31M | 9.23M | 10.6M | 8.38M |
| Income Before Tax | (144.01M) | (109.9M) | (62.76M) | (19.52M) | 3.04M |
| Pre-Tax Margin | -26.6% | -18.4% | -9.4% | -2.5% | 0.3% |
| Income Tax Expense | 263K | 497K | 433K | 875K | 1.4M |
| Net Income | (144.27M) | (110.39M) | (63.2M) | (20.39M) | 1.64M |
| Net Margin | -26.7% | -18.5% | -9.4% | -2.6% | 0.2% |
| EPS (Basic) | (1.39) | (0.96) | (0.54) | (0.17) | 0.01 |
| EPS (Diluted) | (1.39) | (0.96) | (0.54) | (0.17) | 0.01 |
| Weighted Avg Shares | 113.62M | 114.94M | 117.39M | 120.39M | 122.67M |
| Weighted Avg Shares (Diluted) | 113.62M | 114.94M | 117.39M | 120.39M | 125.1M |
Warby Parker Inc.
NYSE:WRBY
Intrinsic Alpha fair value
Locked
Current Price
$28.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.